Analysts await BioSpecifics Technologies Corp (NASDAQ:BSTC) to report earnings on Mar, 14 for the fiscal quarter ending Dec 2015.

They expect $0.33 EPS, up 18.18% or $0.06 from last year’s $0.27 per share.

At the moment 1 analyst is watching BioSpecifics Technologies Corp (NASDAQ:BSTC), 0 rate it “Buy”, 1 “Outperform”, 0 “Underperform”, 0 “Sell”, while 0 “Hold”.

Looking forward, for the quarter ending Mar-16, 1 analyst has a mean sales target of 6.25 million. For the quarter ending Jun-16, 1 analyst has a mean sales target of 6.75 million whilst for the year ending Dec-16, 1 analyst has a mean target of 28.00 million.

In terms of earnings per share, 1 analyst has a 0.37 EPS mean target for the quarter ending Mar-16, for the quarter ending Jun-16, 1 analyst has a 0.41 EPS mean target and for the quarter ending Jun-16 there are 1 estimate of 1.72 EPS.

Total shares held by institutions as of the most recent company filings are 4,075,454 with a reported 600,807 bought and 73,094 sold. These holdings make up 59.05% of the company’s outstanding shares.

The stock increased 3.00% or $1.04 during the last trading session.